NO961547L - Flavinderivater som anti-virusmidler - Google Patents

Flavinderivater som anti-virusmidler

Info

Publication number
NO961547L
NO961547L NO961547A NO961547A NO961547L NO 961547 L NO961547 L NO 961547L NO 961547 A NO961547 A NO 961547A NO 961547 A NO961547 A NO 961547A NO 961547 L NO961547 L NO 961547L
Authority
NO
Norway
Prior art keywords
viral agents
flavin derivatives
derivatives
flavin
riboflavin
Prior art date
Application number
NO961547A
Other languages
English (en)
Norwegian (no)
Other versions
NO961547D0 (no
Inventor
Washington Odur Ayuko
Original Assignee
Radopath Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Radopath Ltd filed Critical Radopath Ltd
Publication of NO961547D0 publication Critical patent/NO961547D0/no
Publication of NO961547L publication Critical patent/NO961547L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO961547A 1993-10-19 1996-04-18 Flavinderivater som anti-virusmidler NO961547L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939321558A GB9321558D0 (en) 1993-10-19 1993-10-19 Anti-viral agents
PCT/GB1994/002292 WO1995011028A1 (en) 1993-10-19 1994-10-19 Flavin derivatives as anti-viral agents

Publications (2)

Publication Number Publication Date
NO961547D0 NO961547D0 (no) 1996-04-18
NO961547L true NO961547L (no) 1996-06-19

Family

ID=10743784

Family Applications (1)

Application Number Title Priority Date Filing Date
NO961547A NO961547L (no) 1993-10-19 1996-04-18 Flavinderivater som anti-virusmidler

Country Status (26)

Country Link
EP (1) EP0739208A1 (es)
JP (1) JPH09505804A (es)
CN (1) CN1140992A (es)
AP (1) AP620A (es)
AU (1) AU7943794A (es)
BG (1) BG100599A (es)
BR (1) BR9407862A (es)
CA (2) CA2123825A1 (es)
CO (1) CO4520283A1 (es)
CZ (1) CZ113796A3 (es)
EE (1) EE9600057A (es)
GB (2) GB9321558D0 (es)
HR (1) HRP940688A2 (es)
HU (1) HUT76322A (es)
IL (1) IL111338A0 (es)
JO (1) JO1866B1 (es)
MA (1) MA23356A1 (es)
MD (1) MD960168A (es)
NO (1) NO961547L (es)
OA (1) OA10579A (es)
PE (1) PE5596A1 (es)
PL (1) PL314008A1 (es)
SK (1) SK50696A3 (es)
UY (1) UY23844A1 (es)
WO (1) WO1995011028A1 (es)
ZA (1) ZA948191B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07188052A (ja) * 1993-12-27 1995-07-25 Sanwa Kagaku Kenkyusho Co Ltd インターフェロン用作用効果増強剤及び該増強剤とインターフェロンとを含有する抗ウイルス活性増強組成物
US5756479A (en) * 1994-12-29 1998-05-26 Research Development Foundation Flavin adenine dinucleotide analogue inhibitors of monoamine oxidase
US9044523B2 (en) 2000-06-15 2015-06-02 Terumo Bct, Inc. Reduction of contaminants in blood and blood products using photosensitizers and peak wavelengths of light
AU2003299486A1 (en) * 2002-05-10 2004-06-03 The Ohio State University Flavin n-oxides: new anti-cancer agents and pathogen eradication agents
ITTO20020622A1 (it) 2002-07-16 2004-01-16 Dayco Europe Srl Gruppo integrato puleggia-smorzatore torsionale
CN100413866C (zh) * 2002-08-02 2008-08-27 中国人民解放军军事医学科学院放射医学研究所 核黄素衍生物及其制备方法与应用
EP2545788A1 (de) * 2011-07-13 2013-01-16 Martin Hulliger Diätisches Mehrkomponentensystem
JP2018131410A (ja) * 2017-02-15 2018-08-23 ヒノキ新薬株式会社 カスパーゼ−３阻害剤とその用途
CN111565715A (zh) * 2017-10-24 2020-08-21 卢内拉生物技术有限公司 Mitoflavoscin：含靶向黄素的酶通过抑制线粒体呼吸作用消除癌症干细胞(CSCS)
CN114126603A (zh) * 2019-07-09 2022-03-01 帝斯曼知识产权资产管理有限公司 用核黄素或dha降低艾拉弗德的病毒活性

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4219545A (en) * 1979-03-23 1980-08-26 Collins Calvin E Treatment of infectious keratoconjunctivitis in animals
US4264601A (en) * 1979-06-12 1981-04-28 The Board Of Regents Of The University Of Oklahoma Antihypertensive agents and their use in treatment of hypertension
US4500524A (en) * 1982-09-15 1985-02-19 Trustees Of Boston University Tranquilizing and reducing or preventing seizures
WO1991002529A2 (en) * 1989-08-14 1991-03-07 John Bennett Kizer Product and method for killing abnormal vertebrate cells
JP2727471B2 (ja) * 1989-09-14 1998-03-11 三井農林株式会社 インフルエンザウィルス感染予防剤
US5192264A (en) * 1989-10-06 1993-03-09 The Beth Israel Hospital Association Methods and apparatus for treating disease states using oxidized lipoproteins
US5217716A (en) * 1990-07-18 1993-06-08 The Beth Israel Hospital Association Method for treating viral infections using oxidized lipoproteins
FR2674753B1 (fr) * 1991-04-02 1995-03-10 Jean Berque Nouvelles indications therapeutiques, en particulier pour le traitement du sida, d'un medicament deja existant et fabrique a partir d'une molecule denuee de contre-indications et d'effets indesirables.
NZ244270A (en) * 1991-09-13 1995-07-26 Eisai Co Ltd Injectable composition comprising riboflavin
WO1993010784A1 (en) * 1991-11-25 1993-06-10 University Of Michigan Therapeutic composition and method for preventing reperfusion injury
JP3073309B2 (ja) * 1992-03-27 2000-08-07 雪印乳業株式会社 シアル酸結合５−デアザフラビン系化合物

Also Published As

Publication number Publication date
GB9321558D0 (en) 1993-12-08
GB9421099D0 (en) 1994-12-07
CA2174552A1 (en) 1995-04-27
BR9407862A (pt) 1997-05-20
OA10579A (en) 2002-06-19
HUT76322A (en) 1997-08-28
WO1995011028A1 (en) 1995-04-27
CO4520283A1 (es) 1997-10-15
PL314008A1 (en) 1996-08-05
CA2123825A1 (en) 1995-04-20
NO961547D0 (no) 1996-04-18
JO1866B1 (en) 1995-12-27
PE5596A1 (es) 1996-04-18
HRP940688A2 (en) 1997-04-30
AU7943794A (en) 1995-05-08
IL111338A0 (en) 1994-12-29
SK50696A3 (en) 1997-01-08
BG100599A (en) 1997-02-28
CZ113796A3 (en) 1996-11-13
MA23356A1 (fr) 1995-07-01
ZA948191B (en) 1995-06-08
HU9601006D0 (en) 1996-06-28
JPH09505804A (ja) 1997-06-10
EP0739208A1 (en) 1996-10-30
UY23844A1 (es) 1995-03-28
AP620A (en) 1997-10-14
GB2283913A (en) 1995-05-24
CN1140992A (zh) 1997-01-22
EE9600057A (et) 1996-10-15
AP9400695A0 (en) 1995-01-31
MD960168A (ro) 1998-04-30

Similar Documents

Publication Publication Date Title
NO20034094L (no) Sammensetninger som omfatter et antidiar±middel og et epotilon eller et epotilonderivat
MY107843A (en) Anti-viral compounds.
DE69215713D1 (de) Protheseimplantat mit zentrierenden Widerlager, deren Hinterkanten sich verengen
ES2051641A1 (es) Procedimientos para la preparacion de compuestos derivados de tiourea.
FI891716A0 (fi) Hiv-proteasinhibitorer, som aer anvaendbara vid behandling av aids.
NO961547L (no) Flavinderivater som anti-virusmidler
NO304374B1 (no) 1-benzensulfonyl-1,3-dihydro-2H-benzimidazol-2-on-derivater, og farmas°ytiske blandinger som inneholder dem
DK0574457T3 (da) Antiviral nucleosidkombination
HUP9904092A2 (hu) Gyógyszerkészítmény HIV és rák kezelésére valamint eljárás előállítására
DK0973735T3 (da) Polyaromatiske antivirale præparater
NO910003D0 (no) Vitamin e derivater og fremgangsmaate for deres fremstilling.
AU3627289A (en) Pharmaceutical products
TR28109A (tr) Duman halinde dezenfekte eden formülasyonlar.
AU4445089A (en) Lactamimides in the treatment of drug-resistant protozoal infections
NO960775D0 (no) Anvendelse av kinoksaliner i kombinasjon med proteaseinhibitorer som legemiddel for behandling av AIDS og/eller HIV-infeksjoner
AU641279B2 (en) Oligosaccharide derivatives
AU2861389A (en) Disubstituted pyridines
ITTO910567A0 (it) Derivati carbostirilici.
DK605589A (da) Anvendelse af aminobenzocycloalkaner eller syreadditionssalte deraf til fremstilling af et farmaceutikum, saaledes fremstillet praeparat og dettes anvendelse
AU3302389A (en) N-alkylamino derivatives of aromatic, tricyclic compounds in the treatment of drug-resistant protozoal infections
NO912382L (no) Farmasoeytiske kombinasjonspreparater som inneholder cefalosporin- og xantinderivater og deres anvendelse.
ES2195439T3 (es) Glicosidos de antraciclina.
NO933628L (no) Fremgangsmaate og blanding for behandling av Herpes-infeksjoner
MY108106A (en) Complexes of polyadenylic acid with polyuridylic acid.
MX9102683A (es) Derivados de cefalosporina, procedimiento para su preparacion y composicion farmaceutica que los contiene.